[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344165-105":59,"doc-detail-344165-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","analysis-of-romo1-expression-levels-and-its-oncogenic-role-in-gastrointestinal-tract-cancers","Analysis of ROMO1 Expression Levels and Its Oncogenic Role in Gastrointestinal Tract Cancers","","Gastrointestinal tract cancers account for approximately one-third of cancer-related deaths, making early diagnosis and effective treatment crucial to reduce morbidity and mortality. ROMO1 is known to contribute to multiple cancers, yet its biological function in gastrointestinal system tumors remains insufficiently clarified. This study investigates ROMO1 expression changes and oncogenic relevance using GEPIA, UALCAN, TIMER, GeneMANIA, TISIDB, and STRING across COAD, ESCA, LIHC, PAAD, and STAD. ROMO1 is significantly elevated in COAD, ESCA, LUHC, and PAAD, and overexpression correlates with clinicopathological features and tumor-infiltrating immune cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/analysis-of-romo1-expression-levels-and-its-oncogenic-role-in-gastrointestinal-tract-cancers/344165/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/analysis-of-romo1-expression-levels-and-its-oncogenic-role-in-gastrointestinal-tract-cancers/344165.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on ROMO1 in gastrointestinal cancers?","Question",{"text":112,"@type":113},"To determine how ROMO1 expression changes and to clarify its oncogenic role in gastrointestinal system cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and bioinformatics tools were used to assess ROMO1?",{"text":117,"@type":113},"GEPIA, UALCAN, TIMER, GeneMANIA, TISIDB, and STRING were used to evaluate ROMO1’s biological functions and associations.",{"name":119,"@type":110,"acceptedAnswer":120},"In which gastrointestinal cancer types is ROMO1 significantly increased?",{"text":121,"@type":113},"ROMO1 is significantly increased in COAD, ESCA, LUHC, and PAAD, with overexpression linked to clinicopathological features.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344165,1790167999,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","# Article\n\nAnalysis of ROMO1 Expression Levels andItsOncogenic Role in  \nGastrointestinal Tract Cancers  \nSelçuk Yaman 1, Osman Akidan 2, Mehmet Vatansever 3, Sema Misir 4and Serap Ozer Yaman 5,*  \nCitation: Yaman, S.; Akidan, O.;Vatansever, M.; Misir, S.; Yaman, S.O.Analysis of ROMO1 ExpressionLevels andItsOncogenic Role inGastrointestinal Tract Cancers. Curr.Issues Mol. Biol. 2024, 46, 14394–14407 .https://doi.org/10.3390/cimb46120863  \nAcademic Editor: Stergios Boussios  \nReceived: 20 November 2024  \nRevised: 15 December 2024  \nAccepted: 18 December 2024  \nPublished: 20 December 2024  \nCopyright: © 2024 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/  \n4.0/) .  \n1 Department of Medical Biochemistry, Trabzon Kanuni Training and Research Hospital, Trabzon 61250, Turkey;dr_selcukyaman@hotmail.com  \n2 Department of Hematology, Mengücek Gazi Education and Research Hospital, Erzincan 24100, Turkey  \n3 Department of Family Medicine, Trabzon Kanuni Training and Research Hospital, Trabzon 61250, Turkey  \n4 Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas 58140, Turkey  \n5 Department of Medical Biochemistry, Trabzon Kanuni Health Practice and Research Hospital, TrabzonFaculty of Medicine, University of Health Sciences, Trabzon 61250, Turkey  \n* Correspondence: serapozer@ktu.edu.tr  \nAbstract: Gastrointestinal tract cancers account for approximately one-third of cancer-related deaths.Early diagnosis and effective treatment are the most important ways to prevent cancer-related mor-bidity and mortality. ROMO1 has been shown to play an important role in many types of cancer.However, the biological function of ROMO1 is still poorly understood in gastrointestinal systemcancers. The aim of this study is to reveal the expression change and oncogenic role of ROMO ingastrointestinal system cancers. Gene Expression Profiling Interactive Analysis (GEPIA), UALCAN,TIMER, GeneMANIA, TISIDB, and STRING were applied to assess the biological function of ROMO1in gastrointestinal cancers (colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), liverhepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma(STAD)) . ROMO1 is significantly increased in COAD, ESCA, LUHC, and PAAD, andthe overexpres-sion of ROMO1 is associated with clinicopathological features. In addition, ROMO1 has been foundtobe closely associated with tumor-infiltrating immune cells in gastrointestinal cancers. ROMO1 isclosely related to the inner mitochondrial membrane proteins (TIMM) family. The study revealedthat ROMO1 is of significant clinical importance for gastrointestinal cancers and may have potentialclinical utility in treatment and prognosis. Functional tests on cell lines derived from these particulargastrointestinal cancers can alsobe performed in vitro to evaluate the impact ofthe ROMO1 geneand other factors, like potential drugs, on the expression of these genes andthe development andprogression of the cancer.  \nKeywords: ROMO1; gastrointestinal cancers; immune cells  \n## 1. Introduction\n\nCancer is a heterogeneous disease characterized by processes such as the excessiveproliferation of cells, dysfunction of cell death mechanisms, invasion, and metastasis [1] .Today, itis one of the leading health problems due to its incidence and mortality rate [2] .Gastrointestinal (GI) tract cancers are a group of cancers ofthe GI tract and digestive organs,such as the stomach, heart, bile ducts, pancreas, esophagus, colon, and rectum [3] . GIcancers account for almost one-third of cancer-related deaths. It has been reported that GIcancers accounted for approximately 26% of the total cancer incidence and approximately35% of all cancer-related deaths in 2018 [4] . GI cancer is estimated to reach 7.5 million newcases and 5.6 million deaths by 2040","cbCairQnluKFrHcp","https://ap.wps.com/l/cbCairQnluKFrHcp","pdf",13626970,14,"English","# Abstract\n# 1. Introduction\n# 2. Materials and Methods\n# 3. Results\n# 4. Discussion\n# 5. Conclusions","[{\"question\":\"What is the main purpose of the study on ROMO1 in gastrointestinal cancers?\",\"answer\":\"To determine how ROMO1 expression changes and to clarify its oncogenic role in gastrointestinal system cancers.\"},{\"question\":\"Which datasets and bioinformatics tools were used to assess ROMO1?\",\"answer\":\"GEPIA, UALCAN, TIMER, GeneMANIA, TISIDB, and STRING were used to evaluate ROMO1’s biological functions and associations.\"},{\"question\":\"In which gastrointestinal cancer types is ROMO1 significantly increased?\",\"answer\":\"ROMO1 is significantly increased in COAD, ESCA, LUHC, and PAAD, with overexpression linked to clinicopathological features.\"}]","Analysis of ROMO1 Expression Levels and Its Oncogenic Role in Gastrointestinal Tract Cancers | PDF",1790053142,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcd8446e98715d98a6e836bc25ca0fab.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb0a90553213a224c30a6d24773addad.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e1b3fa3bc9b6e9304830581ff3ee534.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6af4c486bb41fbfd763f2fdaef4646c.webp",980,1385]